Healthcare -
Biotechnology - NASDAQ - AU
$ 3.42
1.79 %
$ 30.3 M
Market Cap
-0.58
P/E
ATHE - COST OF REVENUE
Cost of Revenue ATHE - Alterity Therapeutics Limited
214 K
LAST VALUE
-23.34%
2 YEAR CAGR
48.48%
5 YEAR CAGR
7.32%
10 YEAR CAGR